Medplus Health Services is in the business of pathological laboratory testing and manufacturing, wholesale trading and contract manufacturing of pharma, fast-moving consumer goods and beauty products and rendering of management services to group companies and holds investments in subsidiary companies.
The company's consolidated net profit increased 18.4% to Rs 3.79 crore on 29.3% jumped in net sales to Rs 1,284.30 crore in Q1 FY24 over Q1 FY23.
The scrip price of Medplus Health Services is Rs 759.75 on BSE.